4//SEC Filing
Wegman Mark N 4
Accession 0001062993-18-003527
CIK 0000875622other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 8:36 PM ET
Size
6.7 KB
Accession
0001062993-18-003527
Insider Transaction Report
Form 4
Wegman Mark N
Director
Transactions
- Sale
Common Stock, $0.001 par value
2018-08-22$52.71/sh−3,802$200,393→ 76,470 total - Sale
Common Stock, $0.001 par value
2018-08-23$52.56/sh−4,698$246,929→ 71,772 total
Footnotes (2)
- [F1]The selling price of $52.7073 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $52.26 to $53.14. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The selling price of $52.5604 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.02 to $52.82. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001405235
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 8:36 PM ET
- Size
- 6.7 KB